<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To compare subcortical involvement of <z:e sem="disease" ids="C0030567" disease_type="Disease or Syndrome" abbrv="PD">Parkinson's disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>) with that of <z:e sem="disease" ids="C0270786" disease_type="Disease or Syndrome" abbrv="">Binswanger's disease</z:e> (BD), we examined visual evoked potentials (VEPs) and somatosensory evoked potentials (SEPs) in 29 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e> and 7 patients with BD and 11 control subjects </plain></SENT>
<SENT sid="1" pm="."><plain>The patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e> were divided into two groups: <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e> without <z:hpo ids='HP_0000726'>dementia</z:hpo> (nD-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>: n = 18) and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e> with <z:hpo ids='HP_0000726'>dementia</z:hpo> (D-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>: n = 11) </plain></SENT>
<SENT sid="2" pm="."><plain>The D-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e> patients showed significantly longer P100 latencies in VEPs compared with the nD-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e> patients or controls </plain></SENT>
<SENT sid="3" pm="."><plain>The P100 latencies were negatively correlated with Mini-Mental State Examination (MMSE) score in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e> patients </plain></SENT>
<SENT sid="4" pm="."><plain>The BD patients showed significantly longer central conduction time (CCT) in SEPs (interpeak latency between N13 and N20 responses) compared with the nD-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e> patients or controls </plain></SENT>
<SENT sid="5" pm="."><plain>There was no correlation between CCT and MMSE score in the BD patients </plain></SENT>
<SENT sid="6" pm="."><plain>These results suggest that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e> has a predilection for sensory system involvement distinct from that of BD </plain></SENT>
<SENT sid="7" pm="."><plain>In D-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>, the visual system seems more vulnerable than the somatosensory system, but almost the reverse is true of BD </plain></SENT>
</text></document>